We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.2B
AUM Growth
+$1.75B
Cap. Flow
+$1.1B
Cap. Flow %
6.8%
Top 10 Hldgs %
54.17%
Holding
115
New
28
Increased
36
Reduced
22
Closed
20

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$784M
2
ESRX
Express Scripts Holding Company
ESRX
+$504M
3
GD icon
General Dynamics
GD
+$348M
4
XL
XL Group Ltd.
XL
+$329M
5
KDP icon
Keurig Dr Pepper
KDP
+$194M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$618M
2
MON
Monsanto Co
MON
+$543M
3
COL
Rockwell Collins
COL
+$151M
4
ABLX
Ablynx NV
ABLX
+$134M
5
PPLI
People Inc
PPLI
+$112M

Sector Composition

Rank Sector Weight
1 Healthcare 19.63%
2 Technology 19.02%
3 Financials 14.39%
4 Communication Services 11.46%
5 Industrials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
76
Zymeworks
ZYME
$1.66B
$11.2M 0.07%
+755,000
New +$11.7M
TECX
77
Tectonic Therapeutic
TECX
$552M
$10.1M 0.06%
+29,450
New +$10.6M
IMMU
78
DELISTED
Immunomedics Inc
IMMU
$9.47M 0.06%
+400,000
New +$8.04M
PF
79
DELISTED
Pinnacle Foods, Inc.
PF
$9.43M 0.06%
+145,000
New +$8.93M
VOYA icon
80
Voya Financial
VOYA
$9.14B
$8.7M 0.05%
185,000
– –
AKRX
81
DELISTED
Akorn Inc
AKRX
$7.3M 0.05%
+440,000
New +$6.75M
SYBX
82
DELISTED
Synlogic
SYBX
$6.73M 0.04%
45,671
-19,329
-30% -$3.1M
PTGX icon
83
Protagonist Therapeutics
PTGX
$8.73B
$6.12M 0.04%
910,229
-103,271
-10% -$793K
TBIO
84
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$5.06M 0.03%
+400,000
New +$4.83M
GCVRZ
85
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.41M 0.02%
6,827,805
– –
PFNX
86
DELISTED
Pfenex Inc.
PFNX
$3.25M 0.02%
+600,000
New +$3.47M
XERS icon
87
Xeris Biopharma Holdings
XERS
$1.42B
$3.03M 0.02%
+159,500
New +$3.1M
TYME
88
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$3M 0.02%
948,390
-481,899
-34% -$1.37M
VEON icon
89
VEON
VEON
$3.76B
$2.38M 0.01%
40,000
-580,040
-94% -$36.3M
MOR
90
DELISTED
MorphoSys AG American Depositary Shares
MOR
$2.17M 0.01%
+71,631
New +$1.97M
KNSA icon
91
Kiniksa Pharmaceuticals
KNSA
$5.95B
$1.99M 0.01%
+114,589
New +$2.07M
SURF
92
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.63M 0.01%
+100,000
New +$1.45M
KZR
93
DELISTED
Kezar Life Sciences
KZR
$1.33M 0.01%
+7,667
New +$1.34M
SPPI
94
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.05M 0.01%
+50,000
New +$926K
BG icon
95
Bunge Global
BG
$20.7B
– –
-690,000
Closed -$51M
LKFT
96
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
– –
-308,260
Closed -$30.8M
CBIO
97
Crescent Biopharma
CBIO
$584M
– –
-2,500
Closed -$4.06M
HAIN icon
98
Hain Celestial
HAIN
$47.1M
– –
-545,000
Closed -$17.5M
PPLI
99
People Inc
PPLI
$3.41B
– –
-4,000,716
Closed -$112M
QCOM icon
100
Qualcomm
QCOM
$170B
– –
-960,000
Closed -$53.2M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Farallon Capital Management held 115 positions worth $16.2B, up 12% from $14.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Farallon Capital Management deployed $1.1B of net new capital in Q2 2018, opening 28 new positions and adding to 36 existing holdings. Its largest new stake was General Dynamics: 1,697,715 shares worth $316M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $618M trimmed.

  • Farallon Capital Management's largest Q2 2018 buy was General Dynamics: 1,697,715 shares worth $316M.
  • Farallon Capital Management added most to Altaba Inc in Q2 2018, an estimated $784M increase.
  • Farallon Capital Management's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $618M.
  • Farallon Capital Management fully exited Monsanto Co in Q2 2018, selling an estimated $543M.
  • Farallon Capital Management's ten largest holdings make up 54% of its $16.2B portfolio in Q2 2018.
  • Farallon Capital Management opened 28 new positions and closed 20 in Q2 2018.
  • Farallon Capital Management's portfolio value rose 12% quarter-over-quarter to $16.2B.

Based on Farallon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.